<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Oxboro Medical International, Inc.
----------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
-----------------------------
(Title of Class of Securities)
691384 20 0
--------------
(CUSIP Number)
Girard P. Miller
Lindquist & Vennum P.L.L.P.
4200 IDS Center
80 South Eighth Street
Minneapolis, Minnesota 55402
Telephone: (612) 371-2467
-------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
July 22 and August 2, 1999
--------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box. / /
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page. The information
required in the remainder of this cover page shall not be deemed to be
"filed" for the purpose of Section 18 of the Securities Exchange Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 Pages
<PAGE>
- ------------------------------
CUSIP No. 691384 20 0
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Kenneth W. Brimmer
(FEIN Not required)
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) / /
(b) /X/
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See instructions) 00 (Cash Reserves)
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(c) / /
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Minnesota
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 80,000
SHARES ---------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 90,000
EACH ---------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 80,000
WITH ---------------------------------------------------------
10 SHARED DISPOSITIVE POWER
90,000
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
170,000
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGRREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (See instructions) /X/
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Assuming 2,227,060 shares outstanding as of the date of the events
which requires the filing of this statement (as presented in the
Company's Form 10-QSB for the quarter ended June 30, 1999), the
amount in Row 11 represents 7.63% of the outstanding shares. These
share totals do not reflect a 1-for-5 reverse stock split, effective
August 13, 1999.
- -------------------------------------------------------------------------------
Page 2 of 5 Pages
<PAGE>
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See instructions)
IN and 00 (IRA Account)
- -------------------------------------------------------------------------------
CUSIP No. 691384 20 0
Item 1. Security and Issuer.
(a) Title of Class of Securities: Common Stock, $.01 par value
(b) Name of Issuer: Oxboro Medical International, Inc.
(c) Address of Issuer's Principal Executive Offices:
13828 Lincoln Street, N.E.
Ham Lake, MN 55304
Item 2. Identity and Background.
(a) Name of Person Filing: Kenneth W. Brimmer, this Schedule 13D also
pertains to Jaye M. Snyder, spouse of Kenneth W. Brimmer, and
such shares are included within the reference herein.
(b) Business Address:
720 South Fifth Street
Hopkins, Minnesota 55343
(c) Principal Occupation or Employment: Business Manager
(d) Conviction in a criminal proceeding during the last five years:
No
(e) Subject, during the last five years, to a judgment, decree or
final order enjoining securities laws violations: No
(f) Citizenship: Mr. Brimmer is a citizen of the United States.
Item 3. Source and Amount of Funds or Other Consideration.
Cash reserves.
Item 4. Purpose of Transaction.
The Reporting Person also exercised an option for 20,000 shares
of common stock on August 2, 1999. This transaction was for
investment purposes.
Page 3 of 5 Pages
<PAGE>
(a) On July 22, 1999, as described in the Issuer's registration
statement on Form S-3, the Reporting Person has agreed to
exercise purchase rights in the Issuer's Rights Offering, to the
extent necessary to ensure the issuer satisfies the net tangible
asset requirement to continue to be listed on the Nasdaq
Smallcap Market.
Item 5. INTEREST IN SECURITIES OF ISSUER
(a) Number and Percentage of Class beneficially owned:
170,000 shares may be deemed beneficially owned within the
meaning of Rule 13d-3 of the Securities Exchange Act of 1934 by
Kenneth W. Brimmer and this represents 7.63% of the 2,227,060
shares shown as outstanding in the Issuer's last Exchange Act
filing, its Form 10- QSB for the quarter ended June 30, 1999.
Share amounts have not been adjusted to reflect a 1-for-5
reverse stock split effected by the Issuer on August 13, 1999.
In addition, under Section 13d-3(b), under some interpretations,
the Reporting Person may be viewed as the beneficial owner of
303,545 shares of the Issuer's Common Stock in which Gary
Copperud individually and as President of CMM Properties, LLC
(who also has reported his beneficial ownership on Schedule
13(d)) has a beneficial interest. If combined, such 170,000
shares and 303,545 shares, would represent 21.26% of the
2,227,060 shares assumed to be outstanding. See Item 6 below.
DISCLAIMER: Pursuant to Rule 13d-3, the Reporting Person
disclaims any interest of any kind, whether beneficial or
otherwise, in the shares of the Issuer owned beneficially by the
entity named above.
(b) For information on voting and dispositive power with respect to
the above listed shares, see Items 5-8 of the cover page.
(c) Recent transactions in Common Stock:
Date of Period No. of Shares Price or Range
----------------- --------------- ----------------
08/02/99 20,000 $1.00
(d) Ability to Direct the Receipt of Dividends or the Proceeds of
Sale of Securities:
Not applicable.
(e) Last Date on Which Reporting Person Ceased to be a 5% Holder:
Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
Page 4 of 5 Pages
<PAGE>
There are no contracts, arrangements, understandings or relationships
(legal or otherwise) There are no contracts, arrangements,
understandings or relationships (legal or otherwise) among the
persons named in Item 2 and between such persons and any person with
respect to any securities of the Issuer, except that as described in
the Issuer's Registration Statement on Form S-3, the Reporting Person
has agreed to exercise purchase rights in the Issuer's Rights
Offering, to the extent necessary to ensure that the Issuer satisfies
the net tangible asset requirement to continue to be listed on the
Nasdaq Smallcap Market. In addition, the Reporting Person has an
informal, unwritten, non-binding understanding with Kenneth Brimmer,
(who is mentioned in Item 5 above and who also is filing a Schedule
13(d)). Such understanding, to date, is to the effect that each will
try (but not necessarily beforehand) to keep the other informed of
any significant purchases or sales which such person makes, and that
each will share, with the other, information concerning the Issuer,
and requests for information addresses to the Issuer, which might
affect the valuation of their respective investments.
Item 7. Material to be Filed as Exhibits.
(a) Registration Statement on Form S-3 as amended of Oxboro Medical
International, Inc. filed on July 22, 1999 is incorporated by
reference herein.
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated: September 22, 1999.
By: /s/ Kenneth W. Brimmer
------------------------
Page 5 of 5 Pages
